#13845 on the rich list of 14,644 insiders
Mark A. Schlossberg
SVP - Legal & General Counsel at Cytokinetics. Based in South San Francisco, California.
$5.3M
in disclosed stock, +$14K (+0.27%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 13845th of 14,644
- Companies held
- 1
- Largest holding
- CYTK, 100.0% of total
- Latest SEC filing
- Mar 15, 2022
What the $5.3M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Cytokinetics CYTK Common Stock | Directly | 103,408 | $51.46 | $5.3M | 100.0% | Form 4, Mar 15, 2022 |
Share counts are the amounts Mark A. Schlossberg reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 13842 | Timothy R. Wright Chief Executive Officer, MiMedx Group. Marietta, GA | $5.3M |
| 13843 | Robert P. Daniels Director, EOG Resources. Houston, TX | $5.3M |
| 13844 | Michael Beckley Director, Appian. Mclean, VA | $5.3M |
| 13845 | Mark A. Schlossberg SVP - Legal & General Counsel, Cytokinetics. South San Francisco, CA | $5.3M |
| 13846 | Jake Bauer Director, Enliven Therapeutics. Durham, NC | $5.3M |
| 13847 | Alexander R. Bradley Chief Financial Officer, First Solar. Phoenix, AZ | $5.3M |
| 13848 | Bradley Thede Favreau Director, MYR Group. Columbia, MO | $5.3M |
Other Cytokinetics insiders
All CYTK insiders- Robert I. Blum$14.4MPresident & CEO. #6642 overall
- Fady Ibraham Malik$7.9MEVP Research & Development. #10353 overall
- David Cragg$7.9MChief HR & Admin Officer. #10469 overall
- Jeffrey Hessekiel$4.8MChief Legal & Admin Officer. #2526 overall
- Brett A. Pletcher$1.7MEVP, Chief Legal Officer. #11108 overall
- Robert E. Landry$421KDirector. #4734 overall
Questions
How much stock does Mark A. Schlossberg own?
Mark A. Schlossberg holds $5,321,376 in listed stock based on SEC filings and current prices, mostly Cytokinetics (CYTK). That ranks 13845th on the Stock Rich List.
Is this Mark A. Schlossberg's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.